Theravance Biopharma, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update
Go back to Theravance Biopharma, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 55.35 +1.78 (3.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.57 | 52 Week High | $3.48 | |||
| Open | $53.58 | 52 Week Low | $0.80 | |||
| Day High | $55.50 | P/E | N/A | |||
| Day Low | $53.31 | EPS | $-1.54 | |||
| Volume | 4,896,198 | |||||
| (NASDAQ: TBPH) | Delayed: 16.97 +0.41 (2.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.56 | 52 Week High | $38.92 | |||
| Open | $16.70 | 52 Week Low | $12.87 | |||
| Day High | $17.10 | P/E | N/A | |||
| Day Low | $16.64 | EPS | $0.00 | |||
| Volume | 676,267 | |||||
